Drug profile · INN
urea
AQUACARE H.P.
urea (AQUACARE H.P.) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — urea
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 20
- Programs
- 6
- Data quality
- 0.84
Quick answer
urea (AQUACARE H.P.) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related patents
-
US 12263159
Fused ring compound having urea structure
granted -
US 11918568
Fused ring compound having urea structure
granted -
US 11266655
Methods and compositions for treating urea cycle disorders
granted -
US 11213529
Salt of substituted urea derivative and use thereof in medicine
granted -
US 11198685
Substituted ureas and methods of making and using same
granted -
US 11014895
Heterocyclic urea compound, and drug composition and application thereof
granted -
US 10683283
Substituted ureas and methods of making and using same
granted -
US 10065934
Substituted urea derivatives and pharmaceutical uses thereof
granted -
US 9040542
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
granted -
US 9029550
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 9000089
Polyurea systems, processes for preparing the same and use thereof for postoperative adhesion barriers
granted -
US 8716320
Antibacteriall heterocyclic ureas
granted -
US 8501783
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 8481552
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
granted -
US 8476281
Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
granted -
US 8222421
Certain substituted ureas, as modulators of kinase activity
granted -
US 8217172
Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea
granted -
US 8188289
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
granted -
US 7820673
Urea derivative, process for producing the same, and use
granted -
EP 2044019
3-OXOISOINDOLIN-1-CARBONSÄUREAMIDDERIVATE ALS ANALGETIKA
granted
Frequently asked questions
What is urea?
urea (AQUACARE H.P.) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for urea?
AQUACARE H.P. is a marketed brand name for urea. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of urea?
urea has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.